We PRP I-NP O 0,2
have VBP I-VP O 3,7
demonstrated VBN I-VP O 8,20
a DT I-NP O 21,22
new JJ I-NP O 23,26
approach NN I-NP O 27,35
to TO I-VP O 36,38
the DT I-NP O 39,42
manufacture NN I-NP I-KP 43,54
of IN I-PP I-KP 55,57
hydrogel NN I-NP I-KP 71,79
scaffolds NNS I-NP I-KP 80,89
by IN I-PP O 90,92
the DT I-NP O 93,96
use NN I-NP O 97,100
of IN I-PP O 101,103
readily RB I-NP I-KP 104,111
available JJ I-NP I-KP 112,121
and CC O I-KP 122,125
fast JJ I-NP I-KP 126,130
throughput NN I-NP I-KP 131,141
methods. NN I-NP I-KP 142,149

The DT I-NP O 151,154
process NN I-NP O 155,162
shows VBZ I-VP O 163,168
effective JJ I-NP I-KP 169,178
pattern NN I-NP I-KP 179,186
transfer NN I-NP I-KP 187,195
by IN I-PP O 196,198
first JJ I-NP O 199,204
embossing VBG I-NP I-KP 205,214
a DT B-NP I-KP 215,216
sacrificial JJ I-NP I-KP 217,228
layer NN I-NP I-KP 229,234
and CC O O 235,238
using VBG I-VP I-KP 239,244
it PRP I-NP I-KP 245,247
as IN I-PP I-KP 248,250
a DT I-NP I-KP 251,252
soluble JJ I-NP I-KP 253,260
mould NN I-NP I-KP 261,266
in IN I-PP I-KP 267,269
the DT I-NP I-KP 270,273
fabrication NN I-NP B-KP 274,285
process. NN I-NP I-KP 286,293

The DT I-NP O 295,298
use NN I-NP O 299,302
of IN I-PP O 303,305
a DT I-NP O 306,307
sacrificial JJ I-NP I-KP 308,319
layer NN I-NP I-KP 320,325
of IN I-PP I-KP 326,328
PAA NNP I-NP I-KP 329,332
imparts NNS I-NP O 333,340
environmental JJ I-NP O 341,354
sensitivity NN I-NP O 355,366
to TO I-VP O 367,369
the DT I-NP O 370,373
hydrogel NN I-NP I-KP 374,382
film NN I-NP I-KP 383,387
on IN I-PP O 388,390
only RB I-NP O 391,395
one CD I-NP O 396,399
surface. NN I-NP I-KP 400,407

The DT I-NP O 409,412
subsequent JJ I-NP O 413,423
swelling NN I-NP I-KP 424,432
of IN I-PP I-KP 433,435
the DT I-NP I-KP 436,439
PAA NNP I-NP B-KP 440,443
network NN I-NP I-KP 462,469
(IPN) NN I-NP O 470,475
in IN I-PP O 476,478
elevated JJ I-NP I-KP 479,487
pH NN I-NP I-KP 488,490
causes VBZ I-VP O 491,497
a DT I-NP O 498,499
swelling VBG I-NP I-KP 500,508
differential JJ I-NP I-KP 509,521
across IN I-PP O 522,528
the DT I-NP O 529,532
film, NN I-NP I-KP 533,537
causing VBG I-VP O 539,546
it PRP I-NP O 547,549
to TO I-VP O 550,552
roll VB I-VP I-KP 553,557
to TO I-VP O 558,560
accommodate VB I-VP I-KP 561,572
the DT I-NP I-KP 573,576
difference NN I-NP I-KP 577,587
in IN I-PP I-KP 588,590
surface NN I-NP I-KP 591,598
area NN I-NP I-KP 599,603
between IN I-PP I-KP 604,611
the DT I-NP I-KP 612,615
two CD I-NP I-KP 616,619
surfaces. NN I-NP I-KP 620,628

The DT I-NP O 630,633
surface NN I-NP O 634,641
functionalization NN I-NP O 642,659
and CC O O 660,663
patterning NN I-NP O 664,674
stages NNS I-NP O 675,681
are VBP I-VP O 682,685
thus RB I-VP O 686,690
combined VBN I-VP O 691,699
into IN I-PP O 700,704
one CD I-NP O 705,708
photolithographic JJ I-NP I-KP 709,726
operation. NN I-NP I-KP 727,736

The DT I-NP O 738,741
net JJ I-NP O 742,745
result NN I-NP O 746,752
is VBZ I-VP O 753,755
a DT I-NP O 756,757
method NN I-NP O 758,764
of IN I-PP O 765,767
producing VBG I-VP I-KP 768,777
environmentally RB I-VP I-KP 778,793
triggered VBN I-VP I-KP 794,803
all DT I-NP I-KP 817,820
hydrogel NN I-NP I-KP 821,829
scaffolds NNS I-NP I-KP 830,839
by IN I-PP O 840,842
a, NN I-NP O 843,844
to TO I-VP O 846,848
the DT I-NP O 849,852
authorsâ€™ NN I-NP O 853,861
knowledge, NN I-NP O 862,871
novel NN I-NP I-KP 873,878
use NN I-NP I-KP 879,882
of IN I-PP I-KP 883,885
sacrificial JJ I-NP I-KP 886,897
layer NN I-NP I-KP 898,903
embossing. NN I-NP I-KP 904,913

The DT I-NP O 915,918
patterned JJ I-NP I-KP 919,928
hydrogel NN I-NP I-KP 929,937
films NNS I-NP I-KP 938,943
can MD I-VP O 944,947
be VB I-VP O 948,950
triggered VBN I-VP I-KP 951,960
consecutively RB O I-KP 961,974
allowing VBG I-VP O 975,983
for IN I-PP O 984,987
successive JJ I-NP O 988,998
rolling NN I-NP I-KP 999,1006
and CC O O 1007,1010
unrolling VBG I-VP I-KP 1011,1020
depending VBG I-VP O 1021,1030
on IN I-PP O 1031,1033
the DT I-NP O 1034,1037
aqueous JJ I-NP I-KP 1038,1045
pH. NN I-NP I-KP 1046,1048

The DT I-NP O 1050,1053
choice NN I-NP O 1054,1060
of IN I-PP O 1061,1063
PEGDMA NNP I-NP I-KP 1064,1070
hydrogel NNP I-NP I-KP 1071,1079
provides VBZ I-VP O 1080,1088
a DT I-NP O 1089,1090
versatile JJ I-NP I-KP 1091,1100
platform NN I-NP I-KP 1101,1109
for IN I-PP I-KP 1110,1113
creating VBG I-VP I-KP 1114,1122
a DT I-NP I-KP 1123,1124
variety NN I-NP I-KP 1125,1132
of IN I-PP I-KP 1133,1135
hydrogel JJ I-NP B-KP 1136,1144
scaffolds, NNS I-NP I-KP 1145,1154
and CC O O 1156,1159
while IN I-PP O 1160,1165
being VBG I-VP O 1166,1171
and CC O O 1184,1187
nontoxic JJ I-NP O 1188,1196
it PRP B-NP O 1197,1199
is VBZ I-VP O 1200,1202
permeable JJ I-NP O 1203,1212
to TO I-VP O 1213,1215
proteins. VB I-VP I-KP 1216,1224

Furthermore RB O O 1226,1237
PEGDMA NNP I-NP I-KP 1238,1244
can MD I-VP O 1245,1248
be VB I-VP O 1249,1251
modified VBN I-VP O 1252,1260
to TO I-VP O 1261,1263
produce VB I-VP I-KP 1264,1271
biodegradable JJ I-NP I-KP 1272,1285
and CC O I-KP 1286,1289
cell NN I-NP I-KP 1290,1294
adhesive JJ I-NP I-KP 1295,1303
hydrogels NNS I-NP I-KP 1304,1313
for IN I-PP O 1314,1317
a DT I-NP O 1318,1319
variety NN I-NP O 1320,1327
of IN I-PP O 1328,1330
biomedical JJ I-NP I-KP 1331,1341
applications. NN I-NP I-KP 1342,1354

